FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/05/052491 [Registered on: 11/05/2023] Trial Registered Prospectively
Last Modified On: 10/05/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   PROVIDING OXYGEN BY NASAL PRONGS AT FLOW MORE THAN 2 LITRES PER MINUTE VERSUS PROVIDING OXYGEN WITH NASAL PRONGS USING CPAP DEVICE IN CHILDREN WITH DIFFICULTY IN BREATHING. 
Scientific Title of Study   TO COMPARE OUTCOMES OF HUMIDIFIED HIGH FLOW NASAL CANNULA VERSUS NASAL CONTINOUS POSITIVE AIRWAY PRESSURE IN CHILDREN WITH RESPIRATORY DISTRESS:A RANDOMISED CONTROLLED TRIAL. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Motukuri Sesha Sarat Chandra 
Designation  Junior Resident 
Affiliation  MGM Medical College  
Address  Room no-360, Third floor, Department of Pediatrics, N6 CIDCO, MGM Medical College.
Room no-360, Third floor, Department of Pediatrics, N6 CIDCO, MGM Medical College.
Aurangabad
MAHARASHTRA
531002
India 
Phone  8096692642  
Fax    
Email  sc73010@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anjali Vasant Kale 
Designation  Professor 
Affiliation  MGM Medical College, Aurangabad 
Address  Room no-360, Third floor, Department of Pediatrics, MGM Medical College, N6 CIDCO, Aurangabad,
N6 CIDCO, MGM Medical College, Aurangabad
Aurangabad
MAHARASHTRA
431001
India 
Phone  9325212376  
Fax    
Email  drkaleav@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Motukuri Sesha Sarat Chandra 
Designation  Junior Resident 
Affiliation  MGM Medical College, Aurangabad 
Address  Room no-360, Department of Pediatrics, N6 Cidco, MGM Medical College, Aurangabad
Room no-360, Department of Pediatrics, N6 Cidco, MGM Medical College, Aurangabad
Aurangabad
MAHARASHTRA
531002
India 
Phone  8096692642  
Fax    
Email  sc73010@gmail.com  
 
Source of Monetary or Material Support  
MGM medical college ,Aurangabad 
 
Primary Sponsor  
Name  Motukuri Sesha Sarat Chandra 
Address  Room no- 360, Third floor, Department of Pediatrics, N6, CIDCO, MGM Medical College Aurangabad.  
Type of Sponsor  Other [Principal Investigator (self ) ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Motukuri Sesha Sarat Chandra  MGM Medical College  room no-360, department of pediatrics, first floor, MGM Hospital, N-6 CIDCO, Aurangabad
Aurangabad
MAHARASHTRA 
8096692642

sc73010@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MGMECRHS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J22||Unspecified acute lower respiratory infection,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Continuous Positive Airway Pressure (CPAP).   Fischer and Paykel Bubble CPAP Pressuried oxygen from central source will be delivered through a flow meter to the patient by a nasal prongs. The amount of CPAP to be delivered will be determined by adjusting the height of water column: 1cm equal to 1cm water pressure. With oxygen flow at 5 liters per minute to achieve saturation of more than 92 percent frequency and duration of device will depend on the patient status that is breathlessness and will be removed if breathlessness decreases  
Intervention  High Flow Nasal Cannula (HFNC)  Eligible Patients Randomized to receive Intervention will be provided high flow oxygen Using MR850 Fischer and Paykel Health Care System. FIo2 from 0.21 to 1 will be adjusted to achieve at least 95 percent of oxygen saturation. flow rate will be started at 6 liters per minute and increased un till continuous airflow is heard at basal lungs bilaterally. frequency and duration of device will depend on the patient status that is breathlessness and will be removed if breathlessness decreases  
 
Inclusion Criteria  
Age From  1.00 Month(s)
Age To  18.00 Year(s)
Gender  Both 
Details  All children from 1 month to 18 years having Respiratory distress 
 
ExclusionCriteria 
Details  Intubation on admission
Children with congenital heart diseases
Children with neurological diseases
Covid positive patients
Children with chest wall deformity
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Success & failure rate of the intervention done. Success is defined as patient not requiring invasive ventilation after the intervention. Failure is defined as patient requiring invasive ventilation.
 
Assessed from time of admission till 72 hours of intervention 
 
Secondary Outcome  
Outcome  TimePoints 
Document complications like abdominal distension, feeding intolerance, nasal mucosal injury, prolonged ICU stay and discharge on oxygen supplementation  After starting intervention till discharge or death  
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/05/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Yes 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   To compare out comes of humidified high flow nasal cannula versus continuous positive airway pressure in children of respiratory distress presenting to tertiary care hospital Aurangabad.
Primary objective:
To compare success rate/failure rate between HFNC & CPAP treatment group.
(success is defined if patient is started on non-invasive ventilation and does not require invasive ventilation throughout the course,
Failure is defined as if patient requiring invasive ventilation after non-invasive ventilation)
Secondary objective:
To study complications like abdominal distension, issue of feeding intolerance, nasal mucosal injury, discharge on oxygen supplementation & prolonged ICU stay.

 
Close